Skip to content
777 Sourcing.

Capability

bispecific and trispecific immunotherapy development

Suppliers
1
States & provinces
1
Countries
1

1 bispecific and trispecific immunotherapy development supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

APTEVO THERAPEUTICS INC

SEATTLE, WA

Aptevo Therapeutics Inc. is a clinical-stage biotechnology company based in Seattle, Washington, focused on developing novel bispecific and trispecific immunotherapies for the treatment of cancer. The company leverages its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies to create therapeutic candidates designed to improve outcomes for cancer patients.

clinical developmentimmuno-oncology drug developmentpreclinical researchproprietary ADAPTIR and ADAPTIR-FLEX platforms

Compiled from public sources

Related capabilities

Other processes offered by the shops that list bispecific and trispecific immunotherapy development.

Browse all capabilities